提供特级Atezolizumab生物类似药,抗人PD-L1单克隆抗体(Atezolizumab Biosimilar, Anti-human PD-L1 Monoclonal Antibody,内毒素≤0.05 EU/mg)。 纯度:>95%(在还原条件下通过SDS-PAGE测定) 运输:Syd Labs研究级Atezolizumab生物类似药,抗人PD-L1单克隆抗体(Atezolizumab Biosimilar, Anti-human PD-L1 Monoclonal Antibody...
产品规格 宿主/亚型 Mouse / IgG1 分类 Monoclonal 类型 Antibody 克隆号 MIH2 抗原 Human CD274 transfected P815 cells 偶联物 FITC 激发/发射光谱 498/517 nm查看光谱 形式 Liquid 浓度 0.1 mg/mL 保存条件 4°C or -20°C if preferred, store in dark ...
随后基于杂交瘤和基因工程等生物技术的发展,2002年,首个全人源化单克隆抗体(monoclonal Antibody,mAb)——阿达木单抗(Humira)成功上市,经受住了市场的考验,同时蛋白类抗体药物的研发也迎来了高峰[2]。抗体药物,尤其是治疗性单克隆抗体药物,在制剂研究和处方开发方面有巨大的应用前景和价值。 2018年的诺贝尔生理...
PD-L1 Rabbit Monoclonal Antibody -20ºC保存,需避免反复冻融。Western一抗稀释液-20℃或4℃保存,一年有效,Western一抗稀释液优先推荐4℃保存,长期不使用可以考虑-20℃保存,但冻融可能会导致出现轻微的浑浊和少量不溶物。 注意事项: 如果本抗体用于Western blot (WB)、免疫荧光(IF)、免疫细胞化学(ICC)等实验...
- 产品规格 宿主/亚型 Rat / IgG2b, kappa 分类 Monoclonal 类型 Antibody 克隆号 10F.9G2 抗原 Mouse CD274 偶联物 PE-Cyanine7 激发/发射光谱 569/780 nm查看光谱 形式 Liquid 浓度 0.2 mg/mL 保存条件 4° C 运输条件 Wet ice RRID AB_2534368 ...
The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-Ll with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this ...
[41] Kikuchi M, Clump D A, Srivastava R M, et al. Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and...
The 10F.9G2™ monoclonal antibody reacts with mouse PD-L1 (programmed death ligand 1) also known as B7-H1 or CD274. PD-L1 is a 40 kDa type I transmembrane protein that belongs to the B7 family of the Ig superfamily. PD-L1 is expressed on T lymphocytes, B lymphocytes, NK cells, ...
Rat Monoclonal PD-L1 Antibody (MIH5) 价格电议 起批量≥1 mg 最小起订电询 供货总量电询 发货地址上海市浦东新区 建议售价￥电议/mg 更新日期2025年02月17日 产品规格见优宁维官网 即时洽谈立即询价查看联系方式 收藏产品发送留言 VIP4年 上海优宁维生物科技股份有限公司A股...
[1] China Oncology Focus Limited Receives Approval by Chinese Authorities to Begin Clinical Trials in Three Separate Cancer Indications Using Sorrento’s Anti-PD-L1 Monoclonal Antibody [2] Lee’s Pharm:自愿性公布–有关肿瘤产品引进和研发的最新情况...